Home » Stocks » RMED

Ra Medical Systems, Inc. (RMED)

Stock Price: $0.199 USD -0.019 (-8.84%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed
After-hours: $0.209 +0.010 (4.82%) Oct 28, 7:54 PM

Stock Price Chart

Key Info

Market Cap 14.43M
Revenue (ttm) 5.57M
Net Income (ttm) -44.98M
Shares Out 72.47M
EPS (ttm) -2.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $0.199
Previous Close $0.218
Change ($) -0.019
Change (%) -8.84%
Day's Open 0.216
Day's Range 0.191 - 0.216
Day's Volume 3,393,246
52-Week Range 0.191 - 2.690

More Stats

Market Cap 14.43M
Enterprise Value n/a
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 72.47M
Float 64.20M
EPS (basic) -2.99
EPS (diluted) -2.80
FCF / Share -1.29
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.00M
Short Ratio 0.42
Short % of Float 3.12%
Beta 1.16
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.59
PB Ratio 0.63
Revenue 5.57M
Operating Income -45.33M
Net Income -44.98M
Free Cash Flow -30.39M
Net Cash 24.19M
Net Cash / Share 0.33
Gross Margin -29.63%
Operating Margin -813.60%
Profit Margin -807.30%
FCF Margin -545.41%
ROA -54.93%
ROE -114.06%
ROIC -211.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(276.70% upside)
Current: $0.199
Target: 0.75
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth15.06%6.59%-1.77%-
Gross Profit-1.652.051.712.84
Operating Income-57.73-31.16-17.76-4.20
Net Income-56.96-30.83-17.77-4.20
Shares Outstanding13.159.237.556.95
Earnings Per Share-4.33-3.34-2.35-0.60
Operating Cash Flow-33.17-18.51-5.52-1.89
Capital Expenditures-0.27-0.58-0.55-0.21
Free Cash Flow-33.44-19.09-6.07-2.10
Cash & Equivalents30.5864.328.243.92
Total Debt3.500.850.060.11
Net Cash / Debt27.0863.478.173.81
Book Value33.1566.71-7.62-0.38
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Ra Medical Systems, Inc.
Country United States
Employees 83
CEO Jonathan Will McGuire

Stock Information

Ticker Symbol RMED
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: RMED
IPO Date August 30, 2018


Ra Medical Systems, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.